Oragenics OGEN Insider Ownership

NYSE OGEN
$0.54 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Historic Insider Ownership Trends

As of August 04, 2026, Oragenics's top three insider holders are Robert C Koski (Director, 1.10Mn shares), Michael O'Keefe Sullivan (Interim Peo, Cfo, 34.26K shares), Robert C Koski (Director, 25.69K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Charles L Pope - 25,471 0 10 Aug, 2023
Robert C Koski - 0 1,102,295 03 Jan, 2023
Alan W Dunton - 25,623 0 09 Dec, 2024
Fred Telling - 948 0 22 Jan, 2026
Michael O'Keefe Sullivan Interim Peo, Cfo 34,255 0 30 Mar, 2022
Kimberly M Murphy Ceo And President 25,000 0 10 Aug, 2023
Janet Huffman Cfo, Secretary And Treasurer 15,000 0 10 Aug, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
12 Dec, 2025 Fred Telling Common Stock D 210 $0.94 948 D S
12 Dec, 2025 Fred Telling Common Stock D 210 $0.94 948 D S
12 Dec, 2025 Fred Telling Common Stock D 210 $0.94 948 D S
11 Dec, 2025 Fred Telling Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Fred Telling Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Fred Telling Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Robert C Koski Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 John P Gandolfo Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Natasha Giordano Non-Employee Director Option (Right to Buy) A 38,320 $0.00 38,320 D A
12 Dec, 2025 Fred Telling Common Stock D 210 $0.94 34,538 D S
11 Dec, 2025 Alan W Dunton Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
12 Dec, 2025 Fred Telling Common Stock D 210 $0.94 34,538 D S
12 Dec, 2025 Fred Telling Common Stock D 210 $0.94 34,538 D S
11 Dec, 2025 Janet Huffman Employee Stock Option (right to buy) A 250,000 $0.00 250,000 D A
11 Dec, 2025 Charles L Pope Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Fred Telling Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Natasha Giordano Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Fred Telling Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
11 Dec, 2025 Fred Telling Non-Employee Director Option (Right to Buy) A 125,000 $0.00 125,000 D A
17 Jun, 2025 Health, Inc. Odyssey Common Stock - OGEN D 2,000 $4.46 5,044 D S